Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer-Reference-Cited by-同舟云学术

Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancer

Published:2015-01-21 Issue:3 Volume:137 Page:537-547
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Barrow Timothy M.¹²,Barault Ludovic¹,Ellsworth Rachel E.³,Harris Holly R.¹,Binder Alexandra M.¹,Valente Allyson L.⁴,Shriver Craig D.⁵,Michels Karin B.¹²⁶

Affiliation:

1. Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital; Harvard Medical School; Boston MA

2. Institute for Prevention and Cancer Epidemiology; University Medical Center Freiburg; Freiburg Germany

3. Clinical Breast Care Project; Henry M. Jackson Foundation for the Advancement of Military Medicine; Windber PA

4. Clinical Breast Care Project, Windber Research Institute; Windber PA

5. Clinical Breast Care Project, Walter Reed National Military Medical Center; Bethesda MD

6. Department of Epidemiology; Harvard School of Public Health; Boston MA

Funder

National Cancer Institute, National Institutes of Health, Department of Health and Human Services

Breast Cancer Research Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference49 articles.

1. Different mechanisms cause imprinting defects at the IGF2/H19 locus in Beckwith-Wiedemann syndrome and Wilms' tumour;Cerrato;Hum Mol Genet,2008

2. Mechanisms of activation of the paternally expressed genes by the Prader-Willi imprinting center in the Prader-Willi/Angelman syndromes domains;Rabinovitz;Proc Natl Acad Sci U S A,2012

3. Correlation between CpG methylation profiles and hormone receptor status in breast cancers;Feng;Breast Cancer Res,2007

4. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation;Feng;Cancer,2008

5. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors;Dalai;Neoplasia,2007

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress;Cellular Signalling;2023-07

2. Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review;The Journal of Clinical Endocrinology & Metabolism;2023-06-02

3. Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells;Toxins;2023-02-09

4. DNA methylation-mediated silencing of Neuronatin promotes hepatocellular carcinoma proliferation through the PI3K-Akt signaling pathway;Life Sciences;2023-01

5. Epigenetics and environment in breast cancer: New paradigms for anti-cancer therapies;Frontiers in Oncology;2022-09-15